SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19965833
Source:
http://linkedlifedata.com/resource/pubmed/id/19965833
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0027686
,
umls-concept:C0031740
,
umls-concept:C0087111
,
umls-concept:C0796392
,
umls-concept:C1517572
,
umls-concept:C1656863
,
umls-concept:C1707455
pubmed:issue
7
pubmed:dateCreated
2010-7-7
pubmed:abstractText
To compare the long-term outcome of photodynamic therapy (PDT) with that of intravitreal bevacizumab (IVB) for myopic choroidal neovascularizations (mCNVs).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0421041
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized
,
http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1468-2079
pubmed:author
pubmed-author:BabaTakayukiT
,
pubmed-author:KitahashiMasayasuM
,
pubmed-author:Kubota-TaniaiMarikoM
,
pubmed-author:MitamuraYoshinoriY
,
pubmed-author:OkadaKyokoK
,
pubmed-author:YamamotoShuichiS
pubmed:issnType
Electronic
pubmed:volume
94
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
864-70
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19965833-Aged
,
pubmed-meshheading:19965833-Angiogenesis Inhibitors
,
pubmed-meshheading:19965833-Antibodies, Monoclonal
,
pubmed-meshheading:19965833-Antibodies, Monoclonal, Humanized
,
pubmed-meshheading:19965833-Atrophy
,
pubmed-meshheading:19965833-Choroid
,
pubmed-meshheading:19965833-Choroidal Neovascularization
,
pubmed-meshheading:19965833-Humans
,
pubmed-meshheading:19965833-Injections, Intraocular
,
pubmed-meshheading:19965833-Middle Aged
,
pubmed-meshheading:19965833-Myopia
,
pubmed-meshheading:19965833-Photochemotherapy
,
pubmed-meshheading:19965833-Retina
,
pubmed-meshheading:19965833-Retrospective Studies
,
pubmed-meshheading:19965833-Visual Acuity
pubmed:year
2010
pubmed:articleTitle
Two-year comparison of photodynamic therapy and intravitreal bevacizumab for treatment of myopic choroidal neovascularisation.
pubmed:affiliation
Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chuo-ku, Chiba, Japan. babatakayuki@nifty.com
pubmed:publicationType
Journal Article
,
Comparative Study
,
Review